glp 1 agonist uses GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 agonists approved for clinical

And in terms of individual drugs, it likely depends on the year

Accepted: Published: Version of record: DOI:

injectable)

1550 of 11 October 2022 adopted by the Italian Ministry of University and Research, CUP D93C22000890001, Project title ON FoodsResearch and innovation network on food and nutrition Sustainability, Safety and SecurityWorking ON Foods. Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

GLP-1 Is considered to be an incretin hormone, which means that it works to promote the production of insulinan important benefit for those who wish to support a healthy blood glucose response

All authors commented on previous versions of the manuscript